Analystreport

Phathom Pharmaceuticals (NASDAQ: PHAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report